Effect of Chitosans and Other Excipients on the Permeation of Ketotifen,FITC-Dextran,and Rhodamine 123 through Caco-2 Cells

Abstract

The determination of drug permeability is an important part of formulation, development, and studying the effect of excipients on drug delivery processes. Ketotifen, FITC-labeled dextran, and Rhodamine 123 permeation was evaluated across Caco-2 cells grown on permeable inserts in the presence of chitosan, N,O-carboxymethyl chitosan (NOCC), Carbopol 934P, Polysorbate 80, and Disodium edetate. Samples with chitosan decrease in transepithelial electrical resistance in a concentration dependent manner not seen with the other excipients used. This corresponds with significant improvement of paracellular permeation of FITC-dextran and Rhodamine 123 compared to the control (p<0.005) but Ketotifen permeation with chitosan does not show statistically significant improvement as compared to the control. Although Rhodamine 123 is a known p-glycoprotein substrate, this data would indicate that the p-glycoprotein transport system is not the rate limiting factor in Rhodamine 123 permeation. Ketotifen permeation is improved slightly in the presence of NOCC, Polysorbate 80, and Disodium edetate. These excipients have been associated with improved transcellular permeation. Carbopol 934P does not improve any of the drug models' permeation. These results clearly show the effectiveness of using Caco-2 cells for screening formulations and excipients for drug development.

Keywords

chitosan Caco-2 cells Ketotifen Rhodamine 123 drug permeability determining drug permeability drug permeability screen in vitro permeability screen.

Get full access to this article

View all access options for this article.

References

Daugherty, A.L. and Mrsny, R.J. (1999). Regulation of the Intestinal Epithelial Paracellular Barrier, Pharm. Sci. Technolo. Today , 2(7): 281—287.

Chantret, I. , Barbat, A. , Dussaulx, E. , Brattain, M.G. and Zweibaum, A. (1988). Epithelial Polarity, Villin Expression, and Enterocytic Differentiation of Cultured Human Colon Carcinoma Cells: A Survey of Twenty Cell Lines, Cancer Res. , 48(7): 1936—1942.

Boisset, M. , Botham, R.P. , Haegele, K.D. , Lenfant, B. and Pachot, J.I. (2000). Absorption of Angiotensin II Antagonists in Ussing Chambers, Caco-2, Perfused Jejunum Loop and in vivo: Importance of Drug Ionisation in the in vitro Prediction of in vivo Absorption, Eur. J. Pharm. Sci., 10(3): 215—224.

Hilgendorf, C. , Spahn-Langguth , H. , Regardh, C.G. , Lipka, E. , Amidon, G.L. and Langguth, P. (2000). Caco-2 versus Caco-2/HT29-MTX co-cultured Cell Lines: Permeabilities via Diffusion, Inside- and Outside-directed Carrier-mediated Transport, J. Pharm. Sci., 89(1): 63—75.

Bailey, C.A. , Bryla, P. and Malick, A.W. (1996). The Use of the Intestinal Epithelial Cell Culture Model, Caco-2, in Pharmaceutical Development, Advanced Drug Delivery Reviews, 22: 85—103.

Chiellini, F. (2006). Perspectives on: in vitro Evaluation of Biomedical Polymers, J. Bioact. Compat. Polym., 21: 257—271.

Lennernas, H. , Palm, K. , Fagerholm , U. and Artursson, P. (1996). Comparison between Active and Passive Drug Transport in Human Intestinal Epithelial (Caco-2) Cells in vitro and Human Jejunum in vivo, International Journal of Pharmaceutics, 127: 103—107.

Junginger, H. and Verhoef, J.C. (1998). Macromolecules as Safe Penetration Enhancers for Hydrophillic Drugs — A Fiction?, Pharmaceutical Science Technology Today, 1(9): 370—376.

Bayat, A. , Sadeghi, A.M.M. , Avadi, M.R. , Amini, M. , Rafiee-Tehrani, M. , Shafiee, A. , et al. (2006). Synthesis of N, N-dimethyl N-ethyl Chitosan as a Carrier for Oral Delivery of Peptide Drugs, J. Bioact. Compat. Polym., 21: 433—444.

10.

Rege, B.D. , Kao, J.P. and Polli, J.E. (2002). Effects of Nonionic Surfactants on Membrane Transporters in Caco-2 Cell Monolayers, Eur. J. Pharm. Sci., 16(4—5): 237—246.

11.

Yumoto, R. , Murakami, T. , Nakamoto, Y. , Hasegawa, R. , Nagai, J. and Takano, M. (1999). Transport of Rhodamine 123, a P-glycoprotein Substrate, across Rat Intestine and Caco-2 Cell Monolayers in the Presence of Cytochrome P-450 3A-related Compounds, J. Pharmacol. Exp. Ther., 289(1): 149—155.

12.

Kibbe, A.H. (2000). Handbook of Pharmaceutical Excipients, 3rd edn, American Pharmaceutical Association, Pharmaceutical Press,Washington, D.C. London, U.K.

13.

Schipper, N.G. , Varum, K.M. and Artursson , P. (1996). Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport across Human Intestinal Epithelial (Caco-2) Cells, Pharm. Res., 13(11): 1686—1692.

14.

Peng, L. , Cheng, X.R. , Wang, J.W. , Xu, D.X. and Wang, G. (2006). Preparation and Evaluation of Porous Chitosan/Collagen Scaffolds for Periodontal Tissue Engineering, J. Bioact. Compat. Polym., 21: 207—220.

15.

Jayakumar, R. , Reis, R.L. and Mano, J.F. (2006). Phosphorous Containing Chitosan Beads for Controlled Oral Drug Delivery, J. Bioact. Compat. Polym., 21: 327—340.

16.

Hejazi, R. and Amiji, M. (2003). Chitosan-based Gastrointestinal Delivery Systems , J. Control Release, 89(2): 151—165.